Biogen (BIIB)

Sales/Maturities of Investments

-$625.70M

Quarterly · Period ending: · USD

BIIB logo

BIIB Sales/Maturities of Investments

Latest reported-$625.70M
BIIB Quarterly Sales/Maturities of Investments ($0.00 → -$625.70M)
High-resolution chart · PNG

BIIB sales/maturities of investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen Sales/Maturities of Investments — Quarterly (USD)
Period endingSales/Maturities of Investments (USD)
-625,700,000
625,700,000
0
56,600,000
0
0
-40,600,000
24,800,000
511,700,000
55,600,000
13,400,000
5,701,600,000
2,133,000,000
440,500,000
566,300,000
1,643,200,000
1,908,200,000
543,600,000
1,379,600,000
575,400,000
633,500,000
910,400,000
2,133,100,000
1,360,800,000
1,490,600,000
2,389,800,000
2,142,699,999
778,100,000
2,076,300,000
1,489,200,000
1,179,000,000
1,192,000,000
2,733,800,000
4,068,900,000
1,093,300,000
888,100,000
1,700,200,000
1,884,300,000
2,193,100,000
2,362,200,000
1,642,500,000
1,181,100,000
699,626,000
2,387,857,000
601,954,000
373,563,000
776,052,000
625,346,000
560,013,000
757,512,000
164,834,000
620,511,000
75,201,000
4,329,506,000
846,235,000
489,450,000
599,497,000
824,434,000
801,694,000
306,628,000
381,753,000
788,083,000
178,331,000
487,820,000
973,236,000
1,029,307,000
998,736,000
696,531,000
579,891,000
1,057,671,000
805,995,000
743,101,000
473,992,000
917,972,000
451,449,000
361,962,000
1,636,693,000
803,675,000
319,042,000
445,040,000
665,180,000
357,877,000
245,659,000
260,093,000
921,543,000
354,839,000
263,331,000
385,712,000
849,450,000
1,701,893,000
698,904,000
177,553,000
120,952,000
121,366,000
104,159,000
98,692,000
102,025,000
100,425,000
84,131,000
106,780,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.